Fighting Cancer with the Immune System
Jun 11
9:00AM – 10:00AM
Linsly-Chittenden Hall | Room: 102 — 63 High Street
Dr. Roy S. Herbst '84, '84 M.S., Ensign Professor of Medicine; Chief of Medical Oncology; Deputy Director for Clinical Affairs, Yale Cancer Center and Smilow Cancer Hospital. Assistant Dean for Translational Research, Yale School of Medicine
Dr. Eric P. Winer '78, '83 MED, Alfred Gilman Professor of Medicine and Pharmacology; Director of the Yale Cancer Center; Physician-in-Chief Smilow Cancer Network; President of the American Society of Clinical Oncology
Discovery of the programmed death pathway, a key player in immune evasion by cancer cells, led to new drugs targeting key immune regulators and revolutionized treatment for many cancer types. Still, better understanding of cancer biology and continued identification of predictive markers of sensitivity and resistance remain critical. New concepts and approaches under way at Yale Cancer Center will be discussed by Dr. Herbst with a focus on target validation and drug discovery. Dr. Winer has devoted his career to breat cancer treatment and research, and has developed new treatment approaches for individuals with breast cancer. He will speak about breast cancer resaerch and the future of cancer treatment more broadly.
Add to Calendar
2022-06-11T09:00:00
2022-06-11T10:00:00
America/New_York
Fighting Cancer with the Immune System
Dr. Roy S. Herbst '84, '84 M.S., Ensign Professor of Medicine; Chief of Medical Oncology; Deputy Director for Clinical Affairs, Yale Cancer Center and Smilow Cancer Hospital. Assistant Dean for Translational Research, Yale School of Medicine
Dr. Eric P. Winer '78, '83 MED, Alfred Gilman Professor of Medicine and Pharmacology; Director of the Yale Cancer Center; Physician-in-Chief Smilow Cancer Network; President of the American Society of Clinical Oncology
Discovery of the programmed death pathway, a key player in immune evasion by cancer cells, led to new drugs targeting key immune regulators and revolutionized treatment for many cancer types. Still, better understanding of cancer biology and continued identification of predictive markers of sensitivity and resistance remain critical. New concepts and approaches under way at Yale Cancer Center will be discussed by Dr. Herbst with a focus on target validation and drug discovery. Dr. Winer has devoted his career to breat cancer treatment and research, and has developed new treatment approaches for individuals with breast cancer. He will speak about breast cancer resaerch and the future of cancer treatment more broadly.
Linsly-Chittenden Hall | Room: 102 — 63 High Street